News

Insulin is commonly known as the key hormone in diabetes. But even for people who don't have the disease, it can be ...
All of a sudden we were just thrown into having to learn everything imaginable the same day that he needed to start shots,” ...
Researchers at The University of Queensland have dosed 5 participants in the first clinical trial of a potentially ...
The former head of Johnson & Johnson’s worldwide medtech business, Ashley McEvoy, has signed up to lead the insulin ...
In a major breakthrough for diabetes treatment, scientists have found a new way to regenerate insulin-producing cells. This ...
Advances in type 1 diabetes technology give people with the condition and their caregivers a little more freedom in their ...
Updated recommendations from an international group of diabetes experts aim to inform diabetes educators about best practices ...
McEvoy, the former leader of Johnson & Johnson’s medtech business, started immediately. Jim Hollingshead, who was CEO of ...
Gut microbes in early life play a key role in shaping insulin production and diabetes risk, with Candida dubliniensis showing ...
Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...
Novo Nordisk will continue offering its top-selling insulin brand, Mixtard, in vial form in India, despite phasing out ...
Iraq partners with German & Dutch (Byton) firms via MoU to build an insulin production plant in Nineveh, boosting local ...